CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −4,470 | $13.17 | $59K | 279,422 |
| 2017-08-21 | dEsparbes Eric SVP and CFO | Sale | −1,825 | $12.20 | $22K | 343,168 |
| 2017-08-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −2,886 | $12.28 | $35K | 267,224 |
| 2017-08-20 | Aguiar Michael W President & Chief Exec Officer | Shares withheld for taxes | −12,917 | $12.28 | $159K | 1,035,967 |
| 2017-08-20 | dEsparbes Eric SVP and CFO | Shares withheld for taxes | −5,770 | $12.28 | $71K | 344,993 |
| 2017-08-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −3,179 | $12.28 | $39K | 283,892 |
| 2017-08-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −2,596 | $12.28 | $32K | 241,557 |
| 2017-05-22 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Sale | −7,815 | $12.01 | $94K | 244,153 |
| 2017-05-22 | dEsparbes Eric SVP and CFO | Sale | −1,825 | $11.85 | $22K | 350,763 |
| 2017-05-20 | Faerm Michael E. Sr VP & Chief Business Officer | Shares withheld for taxes | −3,176 | $11.86 | $38K | 287,071 |
| 2017-05-20 | Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | Shares withheld for taxes | −2,590 | $11.86 | $31K | 251,968 |
| 2017-05-20 | ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | Shares withheld for taxes | −2,228 | $11.86 | $26K | 270,110 |
| 2017-05-20 | dEsparbes Eric SVP and CFO | Shares withheld for taxes | −4,208 | $11.86 | $50K | 352,588 |
| 2017-05-20 | Aguiar Michael W President & Chief Exec Officer | Shares withheld for taxes | −12,897 | $11.86 | $153K | 1,048,884 |
| 2017-04-20 | FRIEDMAN CATHY Director | Grant or award | +19,857 | 73,805 | ||
| 2017-04-20 | Duncan Barbara Gayle Director | Grant or award | +19,857 | 52,318 | ||
| 2017-04-20 | LEPORE PATRICK G Director | Grant or award | +19,857 | 58,278 | ||
| 2017-04-20 | Tyree James L Director | Grant or award | +19,857 | 70,554 | ||
| 2017-04-20 | WALTRIP WILLIAM H Director | Grant or award | +19,857 | 161,789 | ||
| 2017-04-20 | PEPE PAUL Director | Grant or award | +19,857 | 73,805 |
Page 13 of 15 · 297 trades